J. Drumm

Optimization of CoaD Inhibitors against Gram-Negative Organisms through Targeted Metabolomics.

Brian Y Feng, Lisha Wang, Mei Geng, 2017, ACS infectious diseases.

Oxime Fungicides: Highly Active Broad-Spectrum Protectants

D. Kleier, J. B. Adams, S. Pember, 1995 .

Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: intelligent design and evolution through the judicious use of structure-guided design and structure-activity relationships.

P. Charifson, L. Swenson, T. Grossman, 2008, Journal of medicinal chemistry.

Facile preparation of fused ring azolylureas

Tiansheng Wang, S. Tian, D. Deininger, 2007 .

Successful application of serum shift prediction models to the design of dual targeting inhibitors of bacterial gyrase B and topoisomerase IV with improved in vivo efficacy.

P. Charifson, T. Grossman, Tiansheng Wang, 2014, Bioorganic & Medicinal Chemistry Letters.

Anti-Hepatitis C Virus Activity and Toxicity of Type III Phosphatidylinositol-4-Kinase Beta Inhibitors

P. Raman, R. Colvin, R. Tommasi, 2012, Antimicrobial Agents and Chemotherapy.

Synthesis of Fungicidal Triazolones

P. Wojtkowski, R. Brown, J. Drumm, 2002 .

Identification and Evaluation of Novel Acetolactate Synthase Inhibitors as Antifungal Agents

S. Schuierer, J. Tallarico, R. Riedl, 2013, Antimicrobial Agents and Chemotherapy.